Surfactant Protein B in Respiratory Viral Infections

Monday, April 25, 2022

2:15 PM – 2:30 PM US MT

Location: Convention Center: 709/711

CE: Enduring CME: 0.25

Publication Number: 3550.6

Sandra L. Leibel, University of California, San Diego School of Medicine, San Marcos, CA, United States; Ben Croker, UCSD, La Jolla, CA, United States; Rachael N. McVicar, Sanford Burnham Prebys, San Diego, CA, United States; Elizabeth M. Kwong, UC San Diego, San Diego, CA, United States; Rabi Murad, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States; Evan Y. Snyder, Sanford Burnham Prebys Medical Discovery Institute & UCSD, La Jolla, CA, United States

Presenting Author(s)

Sandra Lawrynowicz Leibel, MD MSc
Assistant Professor of Pediatrics
University of California, San Diego School of Medicine
San Marcos, California, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Sandra Lawrynowicz Leibel, MD MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Ben Croker, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rachael N. McVicar, BS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Elizabeth M. Kwong, BS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rabi Murad, Ph.D.: ● Bionano Genomics (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Pfizer (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
● Regulus Therapeutics (Currently Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).

Evan Y. Snyder, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.